Source: Selena Simmons-Duffin,Sydney Lupkin & Deepa Shivaram, NPR

The Biden administration released its list of the first 10 drugs that Medicare will target for reductions the government plans to achieve by negotiating the prices with drugmakers.

The list includes:

• blood thinners Eliquis and Xarelto
• diabetes drugs Jardiance, Januvia, Farxiga and Fiasp/Novolog insulin
• Enbrel and Stelara, drugs used to treat autoimmune diseases like rheumatoid arthritis, psoriasis and Crohn's disease
• Imbruvica, a drug that treats blood cancers

Lower prices for the drugs won't begin until 2026.

Read Full Article: Here are the first 10 drugs Medicare will target for price cuts